Rational Use of Tocilizumab in Critically Ill COVID-19 Patients: A Two-Center Observational Study in the Intensive Care Unit
Background: Tocilizumab (TCZ) is a key treatment for severe COVID-19 but poses risks due to immunosuppression and limited evidence. Concerns about misuse and limited supply necessitate a thorough assessment. This study investigates the utilization patterns and appropriateness of tocilizumab use in critically ill COVID-...